WO1993014122A1 - A human kunitz-type protease inhibitor variant - Google Patents
A human kunitz-type protease inhibitor variant Download PDFInfo
- Publication number
- WO1993014122A1 WO1993014122A1 PCT/DK1993/000005 DK9300005W WO9314122A1 WO 1993014122 A1 WO1993014122 A1 WO 1993014122A1 DK 9300005 W DK9300005 W DK 9300005W WO 9314122 A1 WO9314122 A1 WO 9314122A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- phe
- amino acid
- arg
- variant according
- lys
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8114—Kunitz type inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU33460/93A AU675926B2 (en) | 1992-01-07 | 1993-01-07 | A human kunitz-type protease inhibitor variant |
JP5511993A JPH07504891A (en) | 1992-01-07 | 1993-01-07 | Mutants of human Kunitz-type protease inhibitors |
EP93902106A EP0621872A1 (en) | 1992-01-07 | 1993-01-07 | A human kunitz-type protease inhibitor variant |
NO942549A NO942549L (en) | 1992-01-07 | 1994-07-06 | Kunitz type human protease inhibitor variant |
FI943234A FI943234A0 (en) | 1992-01-07 | 1994-07-06 | Human Kunitzt type protease inhibitor variant |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPCT/DK92/00002 | 1992-01-07 | ||
DK9200002 | 1992-01-07 | ||
DKPCT/DK92/00340 | 1992-11-16 | ||
DK9200340 | 1992-11-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993014122A1 true WO1993014122A1 (en) | 1993-07-22 |
Family
ID=26068350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DK1993/000005 WO1993014122A1 (en) | 1992-01-07 | 1993-01-07 | A human kunitz-type protease inhibitor variant |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0621872A1 (en) |
JP (1) | JPH07504891A (en) |
AU (1) | AU675926B2 (en) |
CA (1) | CA2127246A1 (en) |
CZ (1) | CZ164494A3 (en) |
FI (1) | FI943234A0 (en) |
HU (1) | HUT70293A (en) |
IL (1) | IL104324A0 (en) |
NO (1) | NO942549L (en) |
NZ (1) | NZ246570A (en) |
RU (1) | RU94036773A (en) |
WO (1) | WO1993014122A1 (en) |
ZA (1) | ZA9396B (en) |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995012674A1 (en) * | 1993-11-05 | 1995-05-11 | Zymogenetics, Inc. | Human kunitz-type protease inhibitors |
WO1995018830A2 (en) * | 1994-01-11 | 1995-07-13 | Protein Engineering Corporation | Inhibitors of human plasmin derived from the kunitz domains |
WO1995021601A2 (en) * | 1994-01-11 | 1995-08-17 | Protein Engineering Corporation | Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof |
WO1996004378A2 (en) * | 1994-08-05 | 1996-02-15 | Chiron Corporation | Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
WO1996039519A1 (en) * | 1995-06-05 | 1996-12-12 | Genentech, Inc. | Kunitz type plasma kallikrein inhibitors |
WO1996040224A1 (en) * | 1995-06-07 | 1996-12-19 | Chiron Corporation | Regulation of cytokine synthesis and release |
US5786328A (en) * | 1995-06-05 | 1998-07-28 | Genentech, Inc. | Use of kunitz type plasma kallikrein inhibitors |
US5795954A (en) * | 1994-03-04 | 1998-08-18 | Genentech, Inc. | Factor VIIa inhibitors from Kunitz domain proteins |
WO2000011034A1 (en) * | 1998-08-25 | 2000-03-02 | Knut Kleesiek | A mutant of tissue factor pathway inhibitor, dna sequence and use for detecting thrombotic disorders |
US6103500A (en) * | 1994-08-05 | 2000-08-15 | Chiron Corporation | Production of tissue factor pathway inhibitor |
US6242414B1 (en) | 1995-06-07 | 2001-06-05 | Chiron Corporation | Regulation of cytokine synthesis and release |
WO2001094539A2 (en) * | 2000-05-26 | 2001-12-13 | Shanghai Biowindow Gene Development Inc. | A human kaza1 inhibitory factor 11 and polynucleotide encoding it |
EP1484339A3 (en) * | 1994-01-11 | 2005-03-02 | Dyax Corporation | Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same |
EP1542710A1 (en) * | 2002-08-28 | 2005-06-22 | Dyax Corp. | Methods for preserving organs and tissues |
US6989369B2 (en) | 2003-02-07 | 2006-01-24 | Dyax Corp. | Kunitz domain peptides |
US7064107B2 (en) | 2002-06-07 | 2006-06-20 | Dyax Corp. | Prevention and reduction of blood loss |
US7153829B2 (en) | 2002-06-07 | 2006-12-26 | Dyax Corp. | Kallikrein-inhibitor therapies |
US7235530B2 (en) | 2004-09-27 | 2007-06-26 | Dyax Corporation | Kallikrein inhibitors and anti-thrombolytic agents and uses thereof |
US7276480B1 (en) | 2005-12-30 | 2007-10-02 | Dyax Corp. | Prevention and reduction of blood loss |
US7550427B2 (en) | 2003-08-29 | 2009-06-23 | Dyax Corp. | Poly-pegylated protease inhibitors |
US8450275B2 (en) | 2010-03-19 | 2013-05-28 | Baxter International Inc. | TFPI inhibitors and methods of use |
US8466108B2 (en) | 2008-12-19 | 2013-06-18 | Baxter International Inc. | TFPI inhibitors and methods of use |
US8637454B2 (en) | 2009-01-06 | 2014-01-28 | Dyax Corp. | Treatment of mucositis with kallikrein inhibitors |
US8816055B2 (en) | 2011-01-06 | 2014-08-26 | Dyax Corp. | Plasma kallikrein binding proteins |
US8822653B2 (en) | 2010-01-06 | 2014-09-02 | Dyax Corp. | Plasma kallikrein binding proteins |
US8962563B2 (en) | 2009-12-21 | 2015-02-24 | Baxter International, Inc. | TFPI inhibitors and methods of use |
US11286307B2 (en) | 2015-12-11 | 2022-03-29 | Takeda Pharmaceutical Company Limited | Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5106833A (en) * | 1987-07-23 | 1992-04-21 | Washington University | Coagulation inhibitors |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK408089D0 (en) * | 1989-08-18 | 1989-08-18 | Novo Nordisk As | PROTEINS |
-
1993
- 1993-01-06 IL IL104324A patent/IL104324A0/en unknown
- 1993-01-07 NZ NZ246570A patent/NZ246570A/en unknown
- 1993-01-07 WO PCT/DK1993/000005 patent/WO1993014122A1/en not_active Application Discontinuation
- 1993-01-07 AU AU33460/93A patent/AU675926B2/en not_active Ceased
- 1993-01-07 EP EP93902106A patent/EP0621872A1/en not_active Withdrawn
- 1993-01-07 ZA ZA9396A patent/ZA9396B/en unknown
- 1993-01-07 JP JP5511993A patent/JPH07504891A/en active Pending
- 1993-01-07 RU RU94036773/13A patent/RU94036773A/en unknown
- 1993-01-07 HU HU9401990A patent/HUT70293A/en unknown
- 1993-01-07 CA CA002127246A patent/CA2127246A1/en not_active Abandoned
- 1993-01-07 CZ CZ941644A patent/CZ164494A3/en unknown
-
1994
- 1994-07-06 NO NO942549A patent/NO942549L/en unknown
- 1994-07-06 FI FI943234A patent/FI943234A0/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5106833A (en) * | 1987-07-23 | 1992-04-21 | Washington University | Coagulation inhibitors |
Non-Patent Citations (1)
Title |
---|
Nature, Volume 338, No. --, April 1989, THOMAS J. GIRARD et al., "Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor", page 518 - page 520. * |
Cited By (93)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5728674A (en) * | 1993-11-05 | 1998-03-17 | Zymogenetics, Inc. | Inhibition of blood coagulation by human-kunitz-type inhibitors |
US7541449B2 (en) | 1993-11-05 | 2009-06-02 | Stc.Unm | Human kunitz-type inhibitors and methods relating thereto |
WO1995012674A1 (en) * | 1993-11-05 | 1995-05-11 | Zymogenetics, Inc. | Human kunitz-type protease inhibitors |
US6656746B2 (en) | 1993-11-05 | 2003-12-02 | Zymogenetics, Inc. | Antibodies to human kunitz-type inhibitor |
US5914315A (en) * | 1993-11-05 | 1999-06-22 | Zymogenetics, Inc. | Human Kunitz-type inhibitors and compositions thereof |
EP2055716A1 (en) * | 1994-01-11 | 2009-05-06 | Dyax Corporation | Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same |
US8431359B2 (en) | 1994-01-11 | 2013-04-30 | Dyax Corp. | Nucleic acids encoding polypeptide inhibitors of human plasmin derived from the Kunitz domains |
WO1995018830A3 (en) * | 1994-01-11 | 1995-08-10 | Protein Eng Corp | Inhibitors of human plasmin derived from the kunitz domains |
US7628983B2 (en) | 1994-01-11 | 2009-12-08 | Dyax Corp. | Kallikrein-binding “Kunitz domain” proteins and analogues thereof |
US7919462B2 (en) | 1994-01-11 | 2011-04-05 | Dyax Corp. | Inhibitors of human plasmin derived from the Kunitz domains |
JP2012111779A (en) * | 1994-01-11 | 2012-06-14 | Dyax Corp | Inhibitor of human plasmin derived from kunitz domain |
EP2330127A3 (en) * | 1994-01-11 | 2012-07-11 | Dyax Corporation | Kallikrein-inhibiting Kunitz Domain proteins and nucleic acids encoding the same |
US8283321B2 (en) | 1994-01-11 | 2012-10-09 | Dyax Corp. | Kallikrein-binding “Kunitz domain” proteins and analogues thereof |
US6953674B2 (en) | 1994-01-11 | 2005-10-11 | Dyax Corp. | Inhibitors of human plasmin derived from the kunitz domains |
WO1995018830A2 (en) * | 1994-01-11 | 1995-07-13 | Protein Engineering Corporation | Inhibitors of human plasmin derived from the kunitz domains |
US5795865A (en) * | 1994-01-11 | 1998-08-18 | Dyax Corp. | Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof |
EP1484339A3 (en) * | 1994-01-11 | 2005-03-02 | Dyax Corporation | Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same |
EP1489097A1 (en) * | 1994-01-11 | 2004-12-22 | Dyax Corporation | Inhibitors of human plasmin derived from kunitz domains and nucleic acids encoding the same |
WO1995021601A2 (en) * | 1994-01-11 | 1995-08-17 | Protein Engineering Corporation | Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof |
US6423498B1 (en) | 1994-01-11 | 2002-07-23 | Dyax Corp. | Variegated Kunitz domain peptide library and uses thereof |
WO1995021601A3 (en) * | 1994-01-11 | 1995-09-21 | Protein Eng Corp | Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof |
JP2013249302A (en) * | 1994-01-11 | 2013-12-12 | Dyax Corp | Inhibitors of human plasmin derived from kunitz domains |
US5994125A (en) * | 1994-01-11 | 1999-11-30 | Dyax Corp. | Kallikrein-inhibiting "Kunitz Domain" proteins and analogues thereof |
US6010880A (en) * | 1994-01-11 | 2000-01-04 | Dyax Corp. | Inhibitors of human plasmin derived from the kunitz domains |
JP2009183281A (en) * | 1994-01-11 | 2009-08-20 | Dyax Corp | Inhibitor of human plasmin derived from kunitz domain |
US6071723A (en) * | 1994-01-11 | 2000-06-06 | Dyax Corp. | Inhibitors of human plasmin derived from the Kunitz domains |
US6103499A (en) * | 1994-01-11 | 2000-08-15 | Dyax Corp. | Inhibitors of human plasmin derived from the Kunitz domains |
US8663629B2 (en) | 1994-01-11 | 2014-03-04 | Dyax Corp. | Kallikrein-binding “kunitz domain” proteins and analogues thereof |
US5863893A (en) * | 1994-03-04 | 1999-01-26 | Genentech, Inc. | Factor VIIa inhibitors from kunitz domain proteins |
US5795954A (en) * | 1994-03-04 | 1998-08-18 | Genentech, Inc. | Factor VIIa inhibitors from Kunitz domain proteins |
US5834244A (en) * | 1994-03-04 | 1998-11-10 | Genentech, Inc. | Factor VIIa inhibitors from Kunitz domain proteins |
US5880256A (en) * | 1994-03-04 | 1999-03-09 | Genentech, Inc. | Factor VIIa inhibitors from Kunitz domain proteins |
US5589359A (en) * | 1994-08-05 | 1996-12-31 | Chiron Corporation | Chimeric proteins |
US5696088A (en) * | 1994-08-05 | 1997-12-09 | Chiron Corporation | Chimeric proteins |
US5563123A (en) * | 1994-08-05 | 1996-10-08 | Chiron Corporation | Chimeric proteins |
US6103500A (en) * | 1994-08-05 | 2000-08-15 | Chiron Corporation | Production of tissue factor pathway inhibitor |
US6783960B2 (en) | 1994-08-05 | 2004-08-31 | Chiron Corporation | Chimeric proteins |
WO1996004378A3 (en) * | 1994-08-05 | 1996-03-14 | Chiron Corp | Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
WO1996004378A2 (en) * | 1994-08-05 | 1996-02-15 | Chiron Corporation | Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
US5786328A (en) * | 1995-06-05 | 1998-07-28 | Genentech, Inc. | Use of kunitz type plasma kallikrein inhibitors |
WO1996039519A1 (en) * | 1995-06-05 | 1996-12-12 | Genentech, Inc. | Kunitz type plasma kallikrein inhibitors |
US5780265A (en) * | 1995-06-05 | 1998-07-14 | Genentech, Inc. | Kunitz type plasma kallikrein inhibitors |
US6242414B1 (en) | 1995-06-07 | 2001-06-05 | Chiron Corporation | Regulation of cytokine synthesis and release |
WO1996040224A1 (en) * | 1995-06-07 | 1996-12-19 | Chiron Corporation | Regulation of cytokine synthesis and release |
AU708394B2 (en) * | 1995-06-07 | 1999-08-05 | Novartis Vaccines And Diagnostics, Inc. | Regulation of cytokine synthesis and release |
WO2000011034A1 (en) * | 1998-08-25 | 2000-03-02 | Knut Kleesiek | A mutant of tissue factor pathway inhibitor, dna sequence and use for detecting thrombotic disorders |
WO2001094539A3 (en) * | 2000-05-26 | 2002-03-14 | Shanghai Biowindow Gene Dev | A human kaza1 inhibitory factor 11 and polynucleotide encoding it |
WO2001094539A2 (en) * | 2000-05-26 | 2001-12-13 | Shanghai Biowindow Gene Development Inc. | A human kaza1 inhibitory factor 11 and polynucleotide encoding it |
US7811991B2 (en) | 2002-06-07 | 2010-10-12 | Dyax Corp. | Prevention and reduction of blood loss |
US11344610B2 (en) | 2002-06-07 | 2022-05-31 | Takeda Pharmaceutical Company Limited | Prevention and reduction of blood loss |
US10245307B2 (en) | 2002-06-07 | 2019-04-02 | Dyax Corp. | Prevention and reduction of blood loss |
US7704949B2 (en) | 2002-06-07 | 2010-04-27 | Dyax Corp. | Kallikrein-inhibitor therapies |
US8710007B2 (en) | 2002-06-07 | 2014-04-29 | Dyax Corp. | Prevention and reduction of blood loss |
US7153829B2 (en) | 2002-06-07 | 2006-12-26 | Dyax Corp. | Kallikrein-inhibitor therapies |
US7851442B2 (en) | 2002-06-07 | 2010-12-14 | Dyax Corp. | Prevention and reduction of blood loss |
US9114144B2 (en) | 2002-06-07 | 2015-08-25 | Dyax Corp. | Kallikrein-inhibitor therapies |
US8034775B2 (en) | 2002-06-07 | 2011-10-11 | Dyax Corp. | Kallikrein-inhibitor therapies |
US8124586B2 (en) | 2002-06-07 | 2012-02-28 | Dyax Corp. | Prevention and reduction of blood loss |
US9480733B2 (en) | 2002-06-07 | 2016-11-01 | Dyax Corp. | Prevention and reduction of blood loss |
US7064107B2 (en) | 2002-06-07 | 2006-06-20 | Dyax Corp. | Prevention and reduction of blood loss |
US7718617B2 (en) | 2002-08-28 | 2010-05-18 | Dyax Corp. | Methods for preserving organs and tissues |
EP2386310A3 (en) * | 2002-08-28 | 2012-06-13 | Dyax Corp. | Methods for preserving organs and tissues |
EP1542710A1 (en) * | 2002-08-28 | 2005-06-22 | Dyax Corp. | Methods for preserving organs and tissues |
EP1542710A4 (en) * | 2002-08-28 | 2007-11-28 | Dyax Corp | Methods for preserving organs and tissues |
US7166576B2 (en) | 2002-08-28 | 2007-01-23 | Dyax Corp. | Methods for preserving organs and tissues |
AU2003243413B2 (en) * | 2002-08-28 | 2009-07-09 | Takeda Pharmaceutical Company Limited | Methods for preserving organs and tissues |
US6989369B2 (en) | 2003-02-07 | 2006-01-24 | Dyax Corp. | Kunitz domain peptides |
US7550427B2 (en) | 2003-08-29 | 2009-06-23 | Dyax Corp. | Poly-pegylated protease inhibitors |
US8188045B2 (en) | 2004-09-27 | 2012-05-29 | Dyax Corp. | Kallikrein inhibitors and anti-thrombolytic agents and uses thereof |
US9757437B2 (en) | 2004-09-27 | 2017-09-12 | Dyax Corp. | Kallikrein inhibitors and anti-thrombolytic agents and uses thereof |
US8716225B2 (en) | 2004-09-27 | 2014-05-06 | Dyax Corp. | Kallikrein inhibitors and anti-thrombolytic agents and uses thereof |
US7235530B2 (en) | 2004-09-27 | 2007-06-26 | Dyax Corporation | Kallikrein inhibitors and anti-thrombolytic agents and uses thereof |
US7276480B1 (en) | 2005-12-30 | 2007-10-02 | Dyax Corp. | Prevention and reduction of blood loss |
US9873720B2 (en) | 2008-12-19 | 2018-01-23 | Baxalta GmbH | TFPI inhibitors and methods of use |
US8466108B2 (en) | 2008-12-19 | 2013-06-18 | Baxter International Inc. | TFPI inhibitors and methods of use |
US11001613B2 (en) | 2008-12-19 | 2021-05-11 | Takeda Pharmaceutical Company Limited | TFPI inhibitors and methods of use |
US9777051B2 (en) | 2008-12-19 | 2017-10-03 | Baxalta GmbH | TFPI inhibitors and methods of use |
US8637454B2 (en) | 2009-01-06 | 2014-01-28 | Dyax Corp. | Treatment of mucositis with kallikrein inhibitors |
US8962563B2 (en) | 2009-12-21 | 2015-02-24 | Baxter International, Inc. | TFPI inhibitors and methods of use |
US8822653B2 (en) | 2010-01-06 | 2014-09-02 | Dyax Corp. | Plasma kallikrein binding proteins |
US11505620B2 (en) | 2010-01-06 | 2022-11-22 | Takeda Pharmaceutical Company Limited | Methods of detecting plasma kallikrein |
US10336832B2 (en) | 2010-01-06 | 2019-07-02 | Dyax Corp. | Methods of inhibiting plasma kallikrein in edema patient |
US10201586B2 (en) | 2010-03-19 | 2019-02-12 | Baxalta GmbH | TFPI inhibitors and methods of use |
US9018167B2 (en) | 2010-03-19 | 2015-04-28 | Baxter International Inc. | TFPI inhibitors and methods of use |
US9556230B2 (en) | 2010-03-19 | 2017-01-31 | Baxalta GmbH | TFPI inhibitors and methods of use |
US8450275B2 (en) | 2010-03-19 | 2013-05-28 | Baxter International Inc. | TFPI inhibitors and methods of use |
US11793855B2 (en) | 2010-03-19 | 2023-10-24 | Takeda Pharmaceutical Company Limited | TFPI inhibitors and methods of use |
US10370453B2 (en) | 2011-01-06 | 2019-08-06 | Dyax Corp. | Plasma kallikrein binding proteins |
US9266964B2 (en) | 2011-01-06 | 2016-02-23 | Dyax Corp. | Method of treating hereditary angioedema using plasma kallikrein binding antibodies |
US11401346B2 (en) | 2011-01-06 | 2022-08-02 | Takeda Pharmaceutical Company Limited | Nucleic acids encoding plasma kallikrein binding proteins |
US8816055B2 (en) | 2011-01-06 | 2014-08-26 | Dyax Corp. | Plasma kallikrein binding proteins |
US10800816B2 (en) | 2012-03-21 | 2020-10-13 | Baxalta GmbH | TFPI inhibitors and methods of use |
US11286307B2 (en) | 2015-12-11 | 2022-03-29 | Takeda Pharmaceutical Company Limited | Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack |
Also Published As
Publication number | Publication date |
---|---|
CZ164494A3 (en) | 1994-12-15 |
JPH07504891A (en) | 1995-06-01 |
NO942549D0 (en) | 1994-07-06 |
HU9401990D0 (en) | 1994-09-28 |
EP0621872A1 (en) | 1994-11-02 |
ZA9396B (en) | 1993-08-10 |
IL104324A0 (en) | 1993-05-13 |
NZ246570A (en) | 1996-09-25 |
CA2127246A1 (en) | 1993-07-22 |
AU3346093A (en) | 1993-08-03 |
RU94036773A (en) | 1996-09-27 |
FI943234A (en) | 1994-07-06 |
AU675926B2 (en) | 1997-02-27 |
FI943234A0 (en) | 1994-07-06 |
HUT70293A (en) | 1995-09-28 |
NO942549L (en) | 1994-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU676145B2 (en) | A human kunitz-type protease inhibitor variant | |
AU675926B2 (en) | A human kunitz-type protease inhibitor variant | |
AU675925B2 (en) | A human kunitz-type protease inhibitor variant | |
AU671611B2 (en) | Human kunitz-type protease inhibitor variants | |
EP0621873B1 (en) | A novel human kunitz-type protease inhibitor and variants thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA CZ FI HU JP KR NO NZ PL RU SK US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1993902106 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 246570 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2127246 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 943234 Country of ref document: FI |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV1994-1644 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 1993902106 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: PV1994-1644 Country of ref document: CZ |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1993902106 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: PV1994-1644 Country of ref document: CZ |